BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Bevacizumab
1
Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients
11/15/2022 10:19:35 AM | Browse: 231 | Download: 920
2
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review
7/14/2022 8:05:03 AM | Browse: 291 | Download: 851
3
Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
6/24/2022 9:00:24 AM | Browse: 229 | Download: 488
4
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
9/22/2021 8:09:41 AM | Browse: 388 | Download: 399
5
Colorectal cancer metastatic to the breast: A case report
9/10/2020 5:57:28 AM | Browse: 667 | Download: 928
6
Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
7/20/2020 2:28:50 AM | Browse: 662 | Download: 1231
7
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
4/28/2020 8:04:31 AM | Browse: 712 | Download: 924
8
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
4/15/2020 12:00:00 PM | Browse: 641 | Download: 1025
9
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2/22/2019 4:33:37 AM | Browse: 833 | Download: 784
10
Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review
1/16/2019 8:39:45 AM | Browse: 686 | Download: 1145
11
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
12/14/2018 10:51:23 AM | Browse: 764 | Download: 706
12
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
11/13/2018 8:04:45 AM | Browse: 923 | Download: 1220
13
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
12/20/2016 1:38:00 PM | Browse: 996 | Download: 1444
14
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 957 | Download: 1315
15
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
8/23/2016 8:55:00 AM | Browse: 978 | Download: 1399
16
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
7/15/2016 3:38:00 PM | Browse: 1115 | Download: 1421
17
Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment
9/30/2015 4:28:00 PM | Browse: 1162 | Download: 1402
18
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
6/20/2015 5:38:00 PM | Browse: 1357 | Download: 2317
19
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
5/13/2015 10:38:00 AM | Browse: 976 | Download: 1875
20
Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
4/27/2015 4:29:00 PM | Browse: 1049 | Download: 1442
21
Targeted therapy in first line treatment of RAS wild type colorectal cancer
3/16/2015 6:04:00 PM | Browse: 1012 | Download: 1228
22
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
2/11/2015 4:38:00 PM | Browse: 941 | Download: 927
23
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status
11/19/2014 2:49:00 PM | Browse: 990 | Download: 1101
24
Bevacizumab maintenance in metastatic colorectal cancer: How long?
11/10/2014 12:19:00 PM | Browse: 964 | Download: 1242
25
Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy
10/20/2014 9:54:00 AM | Browse: 1002 | Download: 1322
26
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
9/16/2014 6:10:00 PM | Browse: 1077 | Download: 876
27
Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
9/15/2014 8:54:00 PM | Browse: 1134 | Download: 915
28
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
9/11/2014 8:40:00 PM | Browse: 975 | Download: 1304
29
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
9/3/2014 11:44:00 AM | Browse: 1046 | Download: 1280
30
Bevacizumab for the management of diabetic macular edema
9/1/2014 3:42:00 PM | Browse: 1046 | Download: 840
31
Ranibizumab in diabetic macular edema
9/1/2014 2:50:00 PM | Browse: 1055 | Download: 994
32
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
9/1/2014 10:30:00 AM | Browse: 1198 | Download: 740
33
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1026 | Download: 972
34
Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review
8/26/2014 5:16:00 PM | Browse: 1074 | Download: 732
35
Advances and new perspectives in the treatment of metastatic colon cancer
8/26/2014 4:37:00 PM | Browse: 1066 | Download: 1131
36
Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer
8/26/2014 4:36:00 PM | Browse: 1118 | Download: 722